PubMed:25347993 / 946-1336 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T8","span":{"begin":0,"end":390},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":390},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":390},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T8","span":{"begin":67,"end":71},"obj":"http://purl.obolibrary.org/obo/MAT_0000135"},{"id":"T9","span":{"begin":246,"end":250},"obj":"http://purl.obolibrary.org/obo/MAT_0000135"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"PubmedHPO","denotations":[{"id":"T14","span":{"begin":52,"end":78},"obj":"HP_0030358"},{"id":"T15","span":{"begin":56,"end":78},"obj":"HP_0030357"},{"id":"T16","span":{"begin":67,"end":78},"obj":"HP_0100526"},{"id":"T17","span":{"begin":72,"end":78},"obj":"HP_0002664"},{"id":"T18","span":{"begin":246,"end":257},"obj":"HP_0100526"},{"id":"T19","span":{"begin":251,"end":257},"obj":"HP_0002664"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T38","span":{"begin":56,"end":66},"obj":"FMAID:199060"},{"id":"_T39","span":{"begin":67,"end":71},"obj":"FMAID:169341"},{"id":"_T40","span":{"begin":67,"end":71},"obj":"FMAID:93670"},{"id":"_T41","span":{"begin":67,"end":71},"obj":"FMAID:7195"},{"id":"_T42","span":{"begin":99,"end":108},"obj":"FMAID:66326"},{"id":"_T43","span":{"begin":99,"end":108},"obj":"FMAID:171535"},{"id":"_T44","span":{"begin":246,"end":250},"obj":"FMAID:169341"},{"id":"_T45","span":{"begin":246,"end":250},"obj":"FMAID:93670"},{"id":"_T46","span":{"begin":246,"end":250},"obj":"FMAID:7195"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"uniprot-human","denotations":[{"id":"T4","span":{"begin":198,"end":201},"obj":"http://www.uniprot.org/uniprot/Q6ZQY3"},{"id":"T6","span":{"begin":198,"end":201},"obj":"http://www.uniprot.org/uniprot/Q96L55"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"uniprot-mouse","denotations":[{"id":"T2","span":{"begin":198,"end":201},"obj":"http://www.uniprot.org/uniprot/Q80WP8"},{"id":"T4","span":{"begin":198,"end":201},"obj":"http://www.uniprot.org/uniprot/Q8BVM4"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T10","span":{"begin":52,"end":55},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/604139"},{"id":"T11","span":{"begin":72,"end":78},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/6754"},{"id":"T12","span":{"begin":99,"end":108},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/136615"},{"id":"T13","span":{"begin":251,"end":257},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/6754"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GO-BP","denotations":[{"id":"T7","span":{"begin":133,"end":144},"obj":"http://purl.obolibrary.org/obo/GO_0036065"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GO-CC","denotations":[{"id":"T4","span":{"begin":62,"end":66},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"UBERON-AE","denotations":[{"id":"T10","span":{"begin":67,"end":71},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T11","span":{"begin":246,"end":250},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"EDAM-topics","denotations":[{"id":"T16","span":{"begin":72,"end":78},"obj":"http://edamontology.org/topic_2640"},{"id":"T17","span":{"begin":109,"end":117},"obj":"http://edamontology.org/topic_0634"},{"id":"T18","span":{"begin":214,"end":222},"obj":"http://edamontology.org/topic_0634"},{"id":"T19","span":{"begin":251,"end":257},"obj":"http://edamontology.org/topic_2640"},{"id":"T20","span":{"begin":344,"end":352},"obj":"http://edamontology.org/topic_0634"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"EDAM-DFO","denotations":[{"id":"T15","span":{"begin":320,"end":326},"obj":"http://edamontology.org/operation_2423"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlycoBiology-MAT","denotations":[{"id":"T8","span":{"begin":67,"end":71},"obj":"http://purl.obolibrary.org/obo/MAT_0000135"},{"id":"T9","span":{"begin":246,"end":250},"obj":"http://purl.obolibrary.org/obo/MAT_0000135"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G02780QX\""},{"id":"GlycanIUPAC_T2","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G18425DX\""},{"id":"GlycanIUPAC_T3","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G18630JE\""},{"id":"GlycanIUPAC_T4","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G01004IT\""},{"id":"GlycanIUPAC_T5","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G87301QZ\""},{"id":"GlycanIUPAC_T6","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G39790GW\""},{"id":"GlycanIUPAC_T7","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G42928BB\""},{"id":"GlycanIUPAC_T8","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G51134HC\""},{"id":"GlycanIUPAC_T9","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G68183GR\""},{"id":"GlycanIUPAC_T10","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G46883FA\""},{"id":"GlycanIUPAC_T11","span":{"begin":52,"end":55},"obj":"\"http://rdf.glycoinfo.org/glycan/G54702VY\""}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T8","span":{"begin":67,"end":71},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"PD-UBERON-AE-B_T9","span":{"begin":246,"end":250},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"Anatomy-MAT","denotations":[{"id":"T8","span":{"begin":67,"end":71},"obj":"Body_part"},{"id":"T9","span":{"begin":246,"end":250},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"mat_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MAT_0000135"},{"id":"A9","pred":"mat_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MAT_0000135"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"HP-phenotype","denotations":[{"id":"T10","span":{"begin":52,"end":78},"obj":"Phenotype"},{"id":"T11","span":{"begin":80,"end":85},"obj":"Phenotype"},{"id":"T12","span":{"begin":246,"end":257},"obj":"Phenotype"},{"id":"T13","span":{"begin":327,"end":331},"obj":"Phenotype"},{"id":"T14","span":{"begin":370,"end":375},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"HP:0030358"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"HP:0030358"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"HP:0100526"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"HP:0030357"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"HP:0030358"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"mondo_disease","denotations":[{"id":"T13","span":{"begin":52,"end":78},"obj":"Disease"},{"id":"T14","span":{"begin":80,"end":85},"obj":"Disease"},{"id":"T15","span":{"begin":99,"end":117},"obj":"Disease"},{"id":"T16","span":{"begin":198,"end":201},"obj":"Disease"},{"id":"T18","span":{"begin":246,"end":257},"obj":"Disease"},{"id":"T19","span":{"begin":327,"end":331},"obj":"Disease"},{"id":"T20","span":{"begin":370,"end":375},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0020689"},{"id":"A17","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0004970"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0008903"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0008433"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T10","span":{"begin":52,"end":78},"obj":"Phenotype"},{"id":"T11","span":{"begin":80,"end":85},"obj":"Phenotype"},{"id":"T12","span":{"begin":246,"end":257},"obj":"Phenotype"},{"id":"T13","span":{"begin":327,"end":331},"obj":"Phenotype"},{"id":"T14","span":{"begin":370,"end":375},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"HP:0030358"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"HP:0030358"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"HP:0100526"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"HP:0030357"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"HP:0030358"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T13","span":{"begin":52,"end":78},"obj":"Disease"},{"id":"T14","span":{"begin":80,"end":85},"obj":"Disease"},{"id":"T15","span":{"begin":99,"end":117},"obj":"Disease"},{"id":"T16","span":{"begin":198,"end":201},"obj":"Disease"},{"id":"T18","span":{"begin":246,"end":257},"obj":"Disease"},{"id":"T19","span":{"begin":327,"end":331},"obj":"Disease"},{"id":"T20","span":{"begin":370,"end":375},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0020689"},{"id":"A17","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0004970"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0008903"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0008433"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlyCosmos15-CL","denotations":[{"id":"T1","span":{"begin":302,"end":306},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000096"},{"id":"A2","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000775"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T9","span":{"begin":67,"end":71},"obj":"Body_part"},{"id":"T10","span":{"begin":246,"end":250},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlyCosmos15-MAT","denotations":[{"id":"T8","span":{"begin":67,"end":71},"obj":"Body_part"},{"id":"T9","span":{"begin":246,"end":250},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"mat_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MAT_0000135"},{"id":"A9","pred":"mat_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MAT_0000135"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T8","span":{"begin":0,"end":390},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":390},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":390},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T8","span":{"begin":0,"end":390},"obj":"Sentence"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":307,"end":313},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G66213AR"},{"id":"A2","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G66213AR"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":307,"end":313},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G66213AR"},{"id":"A2","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G66213AR"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"Lectin-Jamboree-Sentence","blocks":[{"id":"T8","span":{"begin":0,"end":390},"obj":"Sentence"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T9","span":{"begin":67,"end":71},"obj":"Body_part"},{"id":"T10","span":{"begin":246,"end":250},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}

{"project":"CL-cell","denotations":[{"id":"T1","span":{"begin":302,"end":306},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000096"},{"id":"A2","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000775"}],"text":"We found that galactosylated A1AT could distinguish non-small-cell lung cancer (NSCLC) from benign pulmonary diseases (AUC = 0.834); fucosylated A1AT showed exceptional capability in distinguishing ADC from benign diseases (AUC = 0.919) or other lung cancer subtypes (AUC = 0.844), and A1AT containing poly-LacNAc could detect SCLC from benign diseases (AUC = 0.905) or NSCLC (AUC = 0.707)."}